Insights

Advanced Biomarker Technology Scailyte's proprietary AI platform, ScaiVision, analyzes extensive single-cell omics data to discover novel biomarker signatures, offering opportunities to collaborate with biotech and pharma companies seeking cutting-edge diagnostics and targeted therapies.

Strategic Partnerships Recent collaborations with clinical-stage biotech firms and participation in major precision medicine events position Scailyte as a key player for partners aiming to accelerate biomarker-driven drug development and personalized treatment solutions.

Funding and Growth With recent grants totaling over 1 million CHF, along with ongoing revenue streams, Scailyte demonstrates financial stability and growth potential, making it an attractive partner for investors and corporate collaborators in the biotech space.

Innovation Focus Recognition through Innosuisse funding and participation in global precision medicine summits signals a strong emphasis on innovation, providing prospects for joint research initiatives and technology licensing opportunities.

Market Expansion Headquartered in Basel with collaborations worldwide, Scailyte’s expanding network in oncology and auto-immunity fields presents sales opportunities for technology licensing, consulting, and support services in precision medicine application development.

Scailyte AG Tech Stack

Scailyte AG uses 8 technology products and services including WordPress, Underscore.js, OWL Carousel, and more. Explore Scailyte AG's tech stack below.

  • WordPress
    Content Management System
  • Underscore.js
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • HubSpot Chat
    Live Chat
  • Piwik
    System Analytics & Monitoring
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

Scailyte AG's Email Address Formats

Scailyte AG uses at least 1 format(s):
Scailyte AG Email FormatsExamplePercentage
Last@scailyte.comDoe@scailyte.com
45%
First.Last@scailyte.comJohn.Doe@scailyte.com
5%
Last@scailyte.comDoe@scailyte.com
45%
First.Last@scailyte.comJohn.Doe@scailyte.com
5%

Frequently Asked Questions

What is Scailyte AG's official website and social media links?

Minus sign iconPlus sign icon
Scailyte AG's official website is scailyte.com and has social profiles on LinkedInCrunchbase.

What is Scailyte AG's SIC code NAICS code?

Minus sign iconPlus sign icon
Scailyte AG's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Scailyte AG have currently?

Minus sign iconPlus sign icon
As of February 2026, Scailyte AG has approximately 21 employees across 1 continents, including Europe. Key team members include Chief Financial Officer: A. D.Head Of Genai Adoption: S. M.Co-Founder And Ceo: P. N.. Explore Scailyte AG's employee directory with LeadIQ.

What industry does Scailyte AG belong to?

Minus sign iconPlus sign icon
Scailyte AG operates in the Biotechnology Research industry.

What technology does Scailyte AG use?

Minus sign iconPlus sign icon
Scailyte AG's tech stack includes WordPressUnderscore.jsOWL CarouseljQuery MigrateHubSpot ChatPiwikApacheApache HTTP Server.

What is Scailyte AG's email format?

Minus sign iconPlus sign icon
Scailyte AG's email format typically follows the pattern of Last@scailyte.com. Find more Scailyte AG email formats with LeadIQ.

How much funding has Scailyte AG raised to date?

Minus sign iconPlus sign icon
As of February 2026, Scailyte AG has raised $1.8M in funding. The last funding round occurred on Dec 04, 2023 for $1.8M.

When was Scailyte AG founded?

Minus sign iconPlus sign icon
Scailyte AG was founded in 2017.

Scailyte AG

Biotechnology ResearchBasel-stadt, Switzerland11-50 Employees

True precision medicine through single-cell science. 

Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles.  The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality.

If you want to partner with, reach out to contact@scailyte.com
 
More information about our company, technology & services you can find on our website - https://scailyte.com

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $1.8M

    Scailyte AG has raised a total of $1.8M of funding over 9 rounds. Their latest funding round was raised on Dec 04, 2023 in the amount of $1.8M.

  • $1M$10M

    Scailyte AG's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1.8M

    Scailyte AG has raised a total of $1.8M of funding over 9 rounds. Their latest funding round was raised on Dec 04, 2023 in the amount of $1.8M.

  • $1M$10M

    Scailyte AG's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.